KYTX Kyverna Therapeutics, Inc.
Healthcare$8.61-0.69%ClosedMarket Cap: $377.0M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$30.75
Target (Median)
$32.50
Target Range
$25.00 - $33.00
Upside from current price: 257.1%
Rating Distribution
2 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-13 | JP Morgan | maintain | Overweight | Overweight |
| 2025-12-16 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-12-04 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-10-30 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-10-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-05-27 | HC Wainwright & Co. | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.47 | $12.5M | 5 |
| Fri Dec 31 | $-2.94 | $17.5M | 5 |
| Sun Dec 31 | $-2.34 | $53.2M | 3 |
| Mon Dec 31 | $-3.65 | $174.6M | 1 |